Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.

@article{Ong2012MicroarrayAR,
  title={Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.},
  author={Pei-Shi Ong and S Chan and Paul C Ho},
  journal={European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences},
  year={2012},
  volume={45 3},
  pages={367-78}
}
The potential of arsenic trioxide (As(2)O(3)) for use as a novel therapy for ovarian cancer treatment has been increasingly recognized. In this study, we developed an arsenic-resistant OVCAR-3 subline (OVCAR-3/AsR) and aimed to identify the molecular mechanisms and signaling pathways contributing to the development of acquired arsenic chemoresistance in ovarian cancer. OVCAR-3/AsR cells were obtained following continual exposure of parental OVCAR-3 cells to low dose As(2)O(3) for 12months… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 103 references

Targeting CCL11 in the treatment of ovarian cancer.

Expert opinion on therapeutic targets • 2010
View 7 Excerpts
Highly Influenced

Epithelial ovarian cancer: A case report

Experimental and therapeutic medicine • 2014

Global cancer

A. 11471–11477. Jemal, F. Bray, +3 authors D. Forman
2011
View 3 Excerpts

Global cancer statistics.

CA: a cancer journal for clinicians • 2011

Similar Papers

Loading similar papers…